These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30035696)

  • 21. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment.
    Valko PO; Waldvogel D; Weller M; Bassetti CL; Held U; Baumann CR
    Eur J Neurol; 2010 Dec; 17(12):1428-36. PubMed ID: 20491889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of coffee consumption and non-motor symptoms in drug-naïve, early-stage Parkinson's disease.
    Cho BH; Choi SM; Kim JT; Kim BC
    Parkinsonism Relat Disord; 2018 May; 50():42-47. PubMed ID: 29449185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.
    Pedersen KF; Alves G; Brønnick K; Aarsland D; Tysnes OB; Larsen JP
    J Neurol; 2010 Feb; 257(2):217-23. PubMed ID: 19705051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anhedonia and its correlation with clinical aspects in Parkinson's disease.
    Nagayama H; Maeda T; Uchiyama T; Hashimoto M; Nomoto N; Kano O; Takahashi T; Terashi H; Hamada S; Hasegawa T; Hatano T; Takahashi T; Baba Y; Sengoku R; Watanabe H; Inoue M; Kadowaki T; Kaneko S; Shimura H; Kubo SI;
    J Neurol Sci; 2017 Jan; 372():403-407. PubMed ID: 27839720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.
    Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C
    Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline predictors of worsening apathy in Parkinson's disease: A prospective longitudinal study.
    Wee N; Kandiah N; Acharyya S; Chander RJ; Ng A; Au WL; Tan LC
    Parkinsonism Relat Disord; 2016 Feb; 23():95-8. PubMed ID: 26705846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of apathy in Parkinson's disease.
    Dujardin K; Sockeel P; Devos D; Delliaux M; Krystkowiak P; Destée A; Defebvre L
    Mov Disord; 2007 Apr; 22(6):778-84. PubMed ID: 17290451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and demographic correlates of apathy in Parkinson's disease.
    Brown DS; Barrett MJ; Flanigan JL; Sperling SA
    J Neurol; 2019 Feb; 266(2):507-514. PubMed ID: 30604055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
    Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE; Weintraub D; Sampaio C; Poewe W; Rascol O; Stebbins GT; Goetz CG
    Mov Disord; 2008 Oct; 23(14):2004-14. PubMed ID: 18709683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiety and depression in patients with Parkinson's disease.
    Yamanishi T; Tachibana H; Oguru M; Matsui K; Toda K; Okuda B; Oka N
    Intern Med; 2013; 52(5):539-45. PubMed ID: 23448761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apathy may herald cognitive decline and dementia in Parkinson's disease.
    Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
    Mov Disord; 2009 Dec; 24(16):2391-7. PubMed ID: 19908317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caregiver report of apathy predicts dementia in Parkinson's disease.
    Fitts W; Weintraub D; Massimo L; Chahine L; Chen-Plotkin A; Duda JE; Hurtig HI; Rick J; Trojanowski JQ; Dahodwala N
    Parkinsonism Relat Disord; 2015 Aug; 21(8):992-5. PubMed ID: 26117435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric properties of apathy scales in Parkinson's disease: a systematic review.
    Mohammad D; Ellis C; Rau A; Ruthirakuhan M; Lanctôt KL; Herrmann N
    Neurodegener Dis Manag; 2018 Aug; 8(4):267-282. PubMed ID: 30040024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-frequency repetitive transcranial magnetic stimulation over the primary foot motor area in Parkinson's disease.
    Maruo T; Hosomi K; Shimokawa T; Kishima H; Oshino S; Morris S; Kageyama Y; Yokoe M; Yoshimine T; Saitoh Y
    Brain Stimul; 2013 Nov; 6(6):884-91. PubMed ID: 23769414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.
    Pedersen KF; Larsen JP; Aarsland D
    Parkinsonism Relat Disord; 2008; 14(3):183-6. PubMed ID: 17889589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.
    Lhommée E; Wojtecki L; Czernecki V; Witt K; Maier F; Tonder L; Timmermann L; Hälbig TD; Pineau F; Durif F; Witjas T; Pinsker M; Mehdorn M; Sixel-Döring F; Kupsch A; Krüger R; Elben S; Chabardès S; Thobois S; Brefel-Courbon C; Ory-Magne F; Regis JM; Maltête D; Sauvaget A; Rau J; Schnitzler A; Schüpbach M; Schade-Brittinger C; Deuschl G; Houeto JL; Krack P;
    Lancet Neurol; 2018 Mar; 17(3):223-231. PubMed ID: 29452685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.